Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

NCT: NCT04030507 · ACTIVE_NOT_RECRUITING

NCT IDNCT04030507
StatusACTIVE_NOT_RECRUITING
Start Date2019-07-26
Completion2028-02
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

This research study is studying the usefulness of magnetic resonance imaging (MRI) to screen for brain metastases (spread of the breast cancer to the brain).

Frequently Asked Questions

What is Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer?

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer is a clinical trial registered under NCT04030507. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04030507?

The current status of NCT04030507 (Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer) is: ACTIVE_NOT_RECRUITING.

When did Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer start?

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer started on 2019-07-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑